Developing Nepal’s medicines pricing policy: evidence synthesis and stakeholders’ consultation

References

• Abdel Rida, N., Mohamed Ibrahim, M. I., & Babar, Z.-U.-D. (2019). Pharmaceutical pricing policies in Qatar and Lebanon: Narrative review and document analysis. Journal of Pharmaceutical Health Services Research, 10(3), 277–287. https://doi.org/10.1111/jphs.12304
   Web of Science ®Google Scholar
• Abdel Rida, N., Mohamed Ibrahim, M. I., & Babar, Z. U. D. (2019). Relationship between pharmaceutical pricing strategies with price, availability, and affordability of cardiovascular disease medicines: Surveys in Qatar and Lebanon. BMC Health Services Research, 19(1), 973. https://doi.org/10.1186/s12913-019-4828-0
   PubMed Web of Science ®Google Scholar
• Babar, Z. U. Pharmaceutical Prices in the 21st Century 2015, X, 411 p. http://www.springer.com/adis/book/978-3-319-12168-0.
   Google Scholar
• Babar, Z. U. D. (2022). Forming a medicines pricing policy for low and middle-income countries (LMICs): The case for Pakistan. Journal of Pharmaceutical Policy and Practice, 15(1), 9. https://doi.org/10.1186/s40545-022-00413-3
   PubMed Web of Science ®Google Scholar
• Cost–plus pricing for setting the price of pharmaceutical products. WHO guideline on country pharmaceutical pricing policies. A plain language summary ISBN 978-92-4-002469-4 (electronic version) ISBN 978-92-4-002470-0 (print version) © World Health Organization 2021. https://apps.who.int/iris/bitstream/handle/10665/341902/9789240024694-eng.pdf.
   Google Scholar
• Critchley, W. (2006). Report of ISTC mission on drug price controls in Vietnam. Vietnam Sweden Health Cooperation Project.
   Google Scholar
• Devkota, A., Paudel, A., Koirala, B., Baral, D., Gautam, S., & Sharma, S. K. (2018). Variation in price of medicines and free medicine availability for treatment of Non-communicable diseases in public sector of eastern Nepal. Journal of Nepal Health Research Council, 16(2), 118–123. https://doi.org/10.3126/jnhrc.v16i2.20295
   PubMedGoogle Scholar
• Drug Bulletin of Nepal. (Volume 30 no 3. April – July 2019) and Department of Drug Administration (DDA) electronic Data Administrative Management System (DAMS) Report. https://www.dda.gov.np/content/drug-bulletin-of-nepal.
   Google Scholar
• Espin, J., Rovira, J., & de Labry, A. O. (2011). Review series on pharmaceutical pricing policies and interventions: Working paper 1: External reference pricing. WHO/HAI Project on Medicine Prices and Availability. WHO/HAI.
   Google Scholar
• External reference pricing. WHO guideline on country pharmaceutical pricing policies. A plain language summary ISBN 978–92–4–002408–3 (electronic version) ISBN 978–92–4–002409–0 (print version) © World Health Organization 2021. https://apps.who.int/iris/bitstream/handle/10665/341894/9789240024083-eng.pdf.
   Google Scholar
• Glaeske, G. (2008). Why are some drugs so expensive? The price policy of pharmaceutical companies - digging the grave of Our health insurance- system. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen, 102(4), 269–277. https://doi.org/10.1016/j.zefq.2008.04.008
   PubMedGoogle Scholar
• Glerum, P. J., Maliepaard, M., de Valk, V., Burger, D. M., & Neef, K. (2020). Drug switching in The Netherlands: A cohort study of 20 active substances. BMC Health Services Research, 20(1), 650. https://doi.org/10.1186/s12913-020-05494-x
   PubMed Web of Science ®Google Scholar
• GO G/O BIG. (2006). Pharmaceutical systems in the comparative analysis. Vienna: Gesundheit Geschaftsbereich OBIG. European Union 2006. O sterreich GmbH.
   Google Scholar
• Hogerzeil, H. V., Humagain, B., Bhuju, G. B., & Trap, B. The pharmaceutical sector in Nepal: Current situation and policy option analysis. July 2022. Prepared for the US Agency for International Development by the USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program. Arlington, VA: Management Sciences for Health, Inc.
   Google Scholar
• Internal reference pricing. WHO guideline on country pharmaceutical pricing policies. A plain language summary ISBN 978-92-4-002457-1 (electronic version) ISBN 978-92-4-002458-8 (print version) © World Health Organization 2021. https://apps.who.int/iris/bitstream/handle/10665/341895/9789240024571-eng.pdf.
   Google Scholar
• Izham, A. M., Slatina Cato, S., Jahic, H., Vlajcic, M., & Catic, T. (12 December 2022). Medicines pricing in Bosnia and Herzegovina-what could be the solution to reduce prices. Value in Health, 12, S252.
   Google Scholar
• Jacobzone, S. (2000). Pharmaceutical policies in OECD Countries: Reconciling social and industrial goals. organization for economic cooperation and development. http://titania.sourceoecd.org/vl1⁄43114515/cl1⁄424/ nw1⁄41/rpsv/workingpapers/18151981/wp_5lgsjhvj7s0x.htm.
   Google Scholar
• Karki, S., Paudel, G., Chaurasia, R., Gautam, A., Baral, S. R., & Bhurtyal, K. M. (2021). Study on cost variation of oral antihypertensive medications available in retail stores across Chitwan. Journal of Chitwan Medical College, 11(37), 41–44. https://doi.org/10.54530/jcmc.467
   Google Scholar
• Khanal, S., Veerman, L., Ewen, M., Nissen, L., & Hollingworth, S. (2019 Jan-Dec). Availability, price, and affordability of essential medicines to manage noncommunicable diseases: A national survey from Nepal. Inquiry, 56, 46958019887572.
   PubMed Web of Science ®Google Scholar
• Koduah, A., Baatiema, L., de Chavez, A. C., Danso-Appiah, A., Kretchy, I. A., Agyepong, I. A., King, N., Ensor, T., & Mirzoev, T. (2022 Dec 1). Implementation of medicines pricing policies in sub-saharan Africa: Systematic review. Systematic Reviews, 11(1), 257. https://doi.org/10.1186/s13643-022-02114-z
   PubMed Web of Science ®Google Scholar
• Kumar, S. (2004). India to extend price controls on drugs. BMJ, 329, 368.
   Google Scholar
• Leopold, C., Vogler, S., Mantel-Teeuwisse, A. K., de Joncheere, K., Leufkens, H. G., & Laing, R. (2012). Differences in external price referencing in Europe: A descriptive overview. Health Policy, 104(1), 50–60. https://doi.org/10.1016/j.healthpol.2011.09.008
   PubMed Web of Science ®Google Scholar
• Mark–up regulation across the pharmaceutical supply and distribution chain. WHO guideline on country pharmaceutical pricing policies. A plain language summary ISBN 978-92-4-002461-8 (electronic version) ISBN 978-92-4-002462-5 (print version) © World Health Organization 2021. https://apps.who.int/iris/bitstream/handle/10665/341897/9789240024618-eng.pdf.
   Google Scholar
• Martikainen, J. E., Maljanen, T., Koskinen, H., & Vogler, S. (2015). Impact of generic price linkage system and reference price system on prices of pharmaceuticals– comparison of Austria and Finland. Journal of Pharmaceutical Policy and Practice, 8(Suppl 1), P2. https://doi.org/10.1186/2052-3211-8-S1-P2
   PubMedGoogle Scholar
• Mishra, S. R., Kandel, N., Subedi, N., & Khanal, V. (2015). Variation in prices of cardiovascular drugs in public and private pharmacies in Nepal. Health Services Research and Managerial Epidemiology, 2, 1–4.
   Google Scholar
• Mossialos, E., Brogan, D., & Walley, T. (2006). Pharmaceutical pricing in Europe: Weighing up the options. International Social Security Review, 59(3), 3–25. https://doi.org/10.1111/j.1468-246X.2006.00245.x
   Google Scholar
• Moye-Holz, D., & Vogler, S. (2022). Comparison of prices and affordability of cancer medicines in 16 countries in Europe and Latin America. Applied Health Economics and Health Policy, 20(1), 67–77. https://doi.org/10.1007/s40258-021-00670-4
   PubMed Web of Science ®Google Scholar
• Nguyen, T. A. (2011). Medicine prices and pricing policies in Vietnam. Ph.D. Thesis. Sydney, Australia: School of Public Health and Community Medicine, The University of New South Wales.
   Google Scholar
• Nguyen, T. A., Knight, R., Roughead, E. E., Brooks, G., & Mant, A. (2014). Policy options for pharmaceutical pricing and purchasing: Issues for low-and middle- income countries. Health Policy and Planning, https://doi.org/10.1093/heapol/czt105
   Web of Science ®Google Scholar
• OECD. (2008). Pharmaceutical pricing policies in a Global Market. Centad. http://www.centad.org/seminar/2.%20Price%20regulation/OECD%20Pharma%20pricing%20policies.pdf.
   Google Scholar
• Paris, V., & Belloni, A. Value in pharmaceutical pricing country profile: Australia - Contextual information on pharmaceutical coverage and pricing. 2014;(November):16.
   Google Scholar
• Paris, V., & Docteur, E. (2008). Pharmaceutical pricing and reimbursement policies in Germany. OECD. http://www.oecd.org/dataoecd/6/57/41586814.pdf.
   Google Scholar
• Poudel, R. S., Poudel, B. K., Shrestha, S., & Piryani, R. M. (2018). Variation in prices of medicines used for the long-term management of non-communicable diseases available in the pharmacy of a tertiary care hospital of Nepal. Journal of Pharmaceutical Health Services Research, 9(4), 293–296. https://doi.org/10.1111/jphs.12237
   Google Scholar
• Poudel, R. S., Shrestha, S., & Poudel, A. (2020 Sep). Quality Use of medicine research network Nepal. Immense price variation of branded generic medicines in low-income countries: The need for an inclusive price control policy. Research in Social and Administrative Pharmacy, 16(9), 1326–1327. https://doi.org/10.1016/j.sapharm.2020.05.002
   PubMed Web of Science ®Google Scholar
• Productivity Commission. (2001). International pharmaceutical price differences. Research report. AusInfo.
   Google Scholar
• Promoting price transparency. WHO guideline on country pharmaceutical pricing policies. A plain language summary ISBN 978-92-4-002463-2 (electronic version) ISBN 978-92-4-002464-9 (print version) © World Health Organization 2021. https://apps.who.int/iris/bitstream/handle/10665/341898/9789240024632-eng.pdf.
   Google Scholar
• Rietveld, A. H., & Haaijer-Ruskamp, F. M. (2002). Policy options for cost containment of pharmaceuticals. In M. N. G. Dukes, F. M. Haaijer-Ruskamp, C. P. De Joncheere, & A. H. Rietveld (Eds.), Drugs and money—prices, affordability and cost containment (7th edn, pp. 29–54). IOS Press.
   Google Scholar
• Schneider, P., & Vogler, S. (2016). Pharmaceutical pricing and reimbursement reform in Kyrgyzstan. WHO Regional Office for Europe.
   Google Scholar
• Shankar, P. R., Subish, P., Mishra, P., & Lalit, M. (2006). Ambiguous pricing of Nepalese medicines. Journal of The Institute of Medicine, 28, 35–84.
   Google Scholar
• Sharma, A., Kaplan, W. A., Satheesh, G., Poudyal, I. P., Gyawali, P., Neupane, D., Bhandari, P. M., Malla, M., Sapkota, S., & Mishra, S. R. (2021). Health system capacity and access barriers to diagnosis and treatment of CVD and diabetes in Nepal. Global Heart, 16(1), 38. https://doi.org/10.5334/gh.927
   PubMed Web of Science ®Google Scholar
• Shrestha, B. (2015). Cost analysis study of oral hypoglycemic agents available in Nepalese market. Medical Journal of Shree Birendra Hospital, 13(2), 6–9. https://doi.org/10.3126/mjsbh.v13i2.13107
   Google Scholar
• Shrestha, R., Ghale, A., Chapagain, B. R., Gyawali, M., & Acharya, T. (2017). Survey on the availability, price and affordability of selected essential medicines for non-communicable diseases in community pharmacies of Kathmandu valley. SAGE Open Medicine, 5, 2050312117738691. https://doi.org/10.1177/2050312117738691
   Google Scholar
• Shrestha, S., Poudel, R. S., Kc, B., Poudel, B. K., Sapkota, B., Sharma, S., & Khadka, A. (2020 Apr 2). Price variation among different brands of anticancer medicines available in hospital pharmacies of Nepal. Journal of Pharmaceutical Policy and Practice, 13(1), 6. https://doi.org/10.1186/s40545-020-0203-0
   PubMed Web of Science ®Google Scholar
• USAID Medicines. Technologies, and Pharmaceutical Services (MTaPS) Program 2019. USAID. Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program Formulation of pricing regulation- CONCEPT NOTE February 2022. (not published).
   Google Scholar
• Value-based pricing. WHO guideline on country pharmaceutical pricing policies. A plain language summary ISBN 978-92-4-002459-5 (electronic version) ISBN 978-92-4-002460-1 (print version) © World Health Organization 2021. https://apps.who.int/iris/bitstream/handle/10665/341896/9789240024595-eng.pdf.
   Google Scholar
• Vogler, S. (2018). Medicine price surveys, analyses and comparisons: Evidence and methodology guidance (1st ed). Academic Press. (eBook ISBN: 9780128132128).
   Google Scholar
• Vogler, S. (2019). Assessment of external price referencing and alternative policies. In S. M. Vogler (Ed.), Medicine price surveys, analyses and comparisons: Evidence, methodology and guidance. Elsevier/ Academic Press.
   Google Scholar
• Vogler, S. (2022 Dec). Prices of new medicines: International analysis and policy options. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen, 175, 96–102. https://doi.org/10.1016/j.zefq.2022.09.009
   PubMed Web of Science ®Google Scholar
• Vogler, S., Habl, C., Leopold, C., Rosian-Schikuta, I., de Joncheere, K., & Thomsen, T. (2008). PPRI—Pharmaceutical Pricing and Reimbursement Information Report. Vienna. http://ppri.oebig.at/ Downloads/Publications/PPRI_Report_final.pdf.
   Google Scholar
• Vogler, S., & Schneider, P. (2019). The practice of external price referencing. Medicine price surveys, analyses and comparisons: Evidence, methodology and guidance. Elsevier/ Academic Press.
   Google Scholar
• WHO guideline on country pharmaceutical pricing policies. second edition. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO.
   Google Scholar
• World Bank Data. https://data.worldbank.org/indicator/SH.XPD.CHEX.PC.CD?locations = NP.
   Google Scholar
• World Data Atlas. Nepal https://knoema.com/atlas/Nepal/topics/Health/Health-Expenditure/Health-expenditure-per-capita#:~:text = Nepal%20%2D%20Current%20expenditure%20on%20health%20per%20capita&text = In%202019%2C%20health%20expenditure%20per,average%20annual%20rate%20of%2010.60%25.
   Google Scholar
• World Health Organization. WHO guideline on country pharmaceutical pricing policies. Geneva. 2013. http://apps.who.int/medicinedocs/docum ents/s21016en/s21016en.pdf. Accessed 4 Nov 2021.
   Google Scholar
• World Health Organization’s Regional Office for South-East Asia (SEARO). Medicines’ price regulatory interventions in the WHO South-East Asia Region: Policy review and recommendations for further research. Final Report. 4 May 2021. https://cdn.who.int/media/docs/default-source/searo/hsd/edm/medicines-price-regulatory-interventions-in-the-who-south-east-asia-region-policy-review-and-recommendations-for-further-research.pdf?sfvrsn = 5ff3b867_1&download = true.
   Google Scholar